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in a cell culture model led to an increase in  KERATIN7  expres-
sion but no change in the cell cycle.  Conclusion: Our study 
supports the concept of a causative role of  LIM1  deficiency 
in the development of multicystic kidney. In a small subset 
of nephroblastomas with a more diffuse expression pattern 
 LIM1  might also contribute to the pathogenesis of these le-
sions.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 A recurring pattern in the pathogenesis of malignant 
tumours appears to be reactivation of embryonically ac-
tive transcription factors, which are silenced during dif-
ferentiation and specialisation in a variety of parenchy-
mal tissues. A typical example is alveolar rhabdomyosar-
coma with reactivation of  PAX3  (paired box 3) and  PAX7 
 (paired box 7) in at least 50% of all cases  [1] . Another im-
pressive example is represented by nephroblastomas. 
Over the past few years genes necessary for kidney devel-
opment like  PAX2  (paired box 2), a transcription factor 
involved in cell proliferation and resistance to apoptosis, 
and  CITED1  (Cbp/p-300 interacting transactivator) have 
been identified to play a role in the tumourigenesis of 
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 Abstract 
 Objective:  Lim1  (Lim homeobox 1) plays an important role 
during rodent renal development; however, its role  in hu-
man kidney development and disease is still unclear.  Meth-
ods: We investigated LIM1 expression during human renal 
development, in dysplastic kidneys and in renal neoplasms 
using immunohistochemistry. RNA levels in renal carcino-
mas were determined by quantitative RT-PCR, and the po-
tential roles of  LIM1  in mesenchymal-epithelial transition 
and cell cycle were investigated in a cell culture model.  Re-
sults: LIM1 was detected in pretubular aggregates, S-shaped 
and comma-shaped bodies as well as immature glomeruli 
between 10 and 30 weeks of gestation. Eleven dysplastic kid-
neys showed no expression of LIM1. In contrast, 12 of 32 
nephroblastomas showed nuclear positivity. One regressive 
nephroblastoma had diffuse expression of LIM1 in tubular 
structures, all others showed focal positivity in mesenchy-
mal, blastemal and epithelial structures. Renal cell carcino-
mas revealed no expression of LIM1. Overexpression of  LIM1 
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nephroblastoma  [2, 3] . Renal organogenesis in mammals 
is a very complex process involving many steps of mesen-
chymal-epithelial transition, multiplex branching of ure-
teric buds and differentiation into a variety of specialized 
epithelial tissues  [4] . The urogenital system develops 
from the intermediate mesoderm by forming epithelial 
structures, called nephric ducts. During this process 
mesenchymal cells undergo transition into differentiated 
epithelial cells  [5] . Lim1 is a protein of the homeobox 
family and possesses high homology between various 
mammalian species. In mice the  Lim1  gene has been 
mapped to chromosome 11 with high homology to the 
human one on chromosome 17q11.2–q12  [6, 7] . During 
renal organogenesis  Lim1  is expressed in multiple struc-
tures of the metanephros. Expression is localized in the 
tips of the ureteric buds, and in derivatives of the meta-
nephric mesenchyme, the pretubular aggregates, the 
comma- and S-shaped bodies as well as immature glom-
eruli in rats and mice  [5, 8] . Renal organogenesis of  Lim1 
 knock-out mice was blocked at an early stage of develop-
ment leading to agenesis of the kidneys accompanied by 
agenesis of the female and male reproductive tract  [9, 10] . 
Mouse embryos with complete  Lim1  deficiency also 
lacked head structures and some of them had a kink in 
the spinal cord. Most of the homozygous embryos died 
around E10, but a few of them survived till birth, being 
delivered stillborn  [9] . In a mouse model with tissue-spe-
cific inactivation of  Lim1  in renal tissues derived from 
metanephric mesenchyme mice died within the first day. 
Inactivation of  Lim1  in nephric duct tissue led to develop-
ment of smaller kidneys, hydronephrosis and hydroure-
ter indicating abnormal formation of the distal ureter  [5] . 
In a mouse model with conditional knock-out of  Lim1  in 
nephric epithelium after nephric duct formation the ani-
mals showed hypoplastic kidneys, hydronephrosis and 
unilateral renal agenesis (20%). The reason of hydrone-
phrosis seems to be vesicoureteral reflux comparable in 
morphology and pathogenetic mechanism with humans 
suffering from this disease  [11] . So far, the role of  LIM1  in 
human disease has hardly been investigated  [12] , only one 
recent study using microarray analysis indicated over-
expression of  LIM1  in a subset of nephroblastomas  [13] .
 In our study we investigated the role of  LIM1  during 
normal human kidney development, cystic renal malde-
velopment and various renal neoplasms, and further ex-
plored the role of this transcription factor in a cell culture 
system. In addition, we evaluated the expression of PAX2 
during renal development, in maldevelopment of the kid-
ney and renal neoplasms.
 Material and Methods 
 Material 
 Formalin-fixed and paraffin-embedded samples of archival 
tissue of embryonal kidneys of different gestational ages, multi-
cystic kidneys, nephroblastomas and renal cell carcinomas were 
included in the study. All samples of nephroblastomas were ob-
tained in collaboration with the Kiel Paediatric Tumour Registry, 
Department of Paediatric Pathology, University of Kiel, Germany.
 Immunohistochemistry 
 Sections of approximately 3–4   m were deparaffinated by xy-
lene and descending alcohol solutions. After pre-treatment for 40 
min in target retrieval solution pH 9 (Dako, Glostrup, Denmark) 
in a microwave and a cooling phase for 20 min at room tempera-
ture, endogenous peroxidase was blocked with 3% H 2 O 2 (Dako) 
for 10 min at room temperature. LIM1 antibodies (Santa Cruz 
Biotechnology Inc., Santa Cruz, Calif., USA) were used in a 1: 100 
dilution in antibody diluent (Dako) for 60 min at room tempera-
ture, followed by incubation for 30 min at room temperature with 
a secondary anti-goat antibody (Bethyl Laboratories, Montgom-
ery, Tex., USA) diluted 1: 1,000. PAX2 staining was performed 
with PAX2 antibodies (Abcam, Cambridge, Mass., USA) in a
1: 500 dilution in antibody diluent (Dako). Dako EnVision TM De-
tection System (Dako) was used as detection system incubating 
slides for 30 min at room temperature followed by 10 min treat-
ment with 3,3  -diaminobenzidine plus chromogen substrate 
(Dako). Alternatively,  PAX2 staining was performed using a 
ready-to-use-antibody (Ventana, Tucson, Ariz., USA) in an auto-
mated Ventana staining system program CC 1 standard (Ventana). 
Specimens were counterstained with Mayer’s hemalaun.
 Quantitative Real-Time-PCR 
 Several 3-  m sections of FFPE samples were deparaffinized 
and stained with Mayer’s hemalaun, followed by manual dissec-
tion under the microscope as described elsewhere  [14] . Total RNA 
from FFPE samples was isolated using the RNAeasyFFPE kit 
(Qiagen, Hilden, Germany). Up to 500 ng of total RNA from FFPE 
samples and cell pellets were reverse transcribed into cDNA using 
a high-capacity cDNA reverse transcription kit (Applied Biosys-
tems, Carlsbad, Calif., USA). Quantitative real-time-PCR (QRT-
PCR) was performed in triplicates with specific primers for  LIM1 , 
 KERATIN7  and  18sRNA  (for primer sequences, see  table 1 ) and 
SYBR green as the detection fluorophore on a 7900T fast-real-
time-PCR-system (Applied Biosystems) (for PCR programme, see 
 table 2 ).  18sRNA  was used as internal control and relative gene 
expression levels were determined as    CT.
 Statistical analysis was performed by paired t test using the 
Graphpad Prism software V5 (Graphpad Inc., San Diego, Calif., 
USA).
 Cell Culture Experiments 
 Cells of the MRC-5 cell line (ATCC-LGC Promchem, Ted-
dington, UK) were grown in 6-well plates to 70% confluence. One 
microgram of pCMV6-AC-GFP vector (Origene, Rockville, Md., 
USA) containing the complete sequence of  LIM1  or 1   g of the 
control vector was used for transfection. To obtain an appropriate 
MOCK vector as a negative control, the pCMV6-Ac-GFP vector 
containing the  LIM1  coding sequence (Origene) was digested us-
ing KpnI restriction enzyme (Fermentas, St. Leon-Rot, Germany) 
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according to the manufacturer’s instructions. Since KpnI restric-
tion sites exist in the multiple cloning site of the vector as well as 
in the  LIM1  open reading frame, a 208-bp fragment was excised. 
The fragments were separated by gel electrophoresis and the vec-
tor fragment was purified on gel. The linearized vector was re-
ligated with T4-DNA Ligase (New England Biolabs, Frankfurt am 
Main, Germany). The lack of the 208-bp fragment resulted in the 
absence of the first ATG of the  LIM1  coding sequence and the in-
troduction of a premature stop codon. Eight microlitres of Lipo-
fectamine 2000 (Invitrogen, Carlsbad, Calif., USA), the vector 
and Opti-MEM  I reduced-serum medium (Invitrogen) to a final 
volume of 100   l were included in the transfection solution. The 
transfection solution was added to 1 ml of medium already cover-
ing the cells and 1 ml of medium 2 h later. After 24 h cells were 
washed with PBS and fresh medium was supplied. Thirty hours 
after transfection cells were harvested and deep frozen in TRIZOL 
(Invitrogen). Total RNA was extracted for QRT-PCR according to 
the manufacturer’s proceedings.
 For cell cycle analysis 1  ! 10 5 cells were collected and resus-
pended in PBS, followed by centrifugation and further washing 
steps with 1% BSA. The cells were finally resuspended in 500   l 
of DNA-prep stain (Beckman Coulter, Brea, Calif., USA) and in-
cubated for 20 min in the dark at room temperature. Cell cycle 
analysis was read on a Cytomics FC 500 (Beckman Coulter).
 Results 
 Kidney Development 
 Samples of 32 regularly developed kidneys of different 
gestational ages from 7 weeks of gestation until the age of 
2 months were included in the study. The samples were 
distributed in terms of gestational age as follows: 1 at 7, 
10, 13 and 14 weeks each, 3 at 15 and 4 at 16 weeks, 3 at 17 
weeks, 2 at 18 weeks, 1 at 19 weeks, 3 at 20 weeks, 3 at 21 
weeks, 1 at 22 and 23 weeks, 2 at 28 weeks, and 1 at 30, 35 
and 40 weeks of gestation each. One of the samples of 28 
weeks represented a 1-day-old preterm delivery. Addi-
tionally, 1 sample each from 2 days and 2 months of age 
were investigated. The apical tips of comma- and S-
shaped bodies showed clear positivity of LIM1 between 
10 and 30 weeks of gestation. Focal positivity was also 
detected in pretubular aggregates and some immature 
glomeruli. The sample of regularly developed kidney 
from 7 and 35 weeks of gestation revealed complete nega-
tivity in 2 different sets of experiments. In the kidney 
from 35 weeks of gestation only a very limited amount of 
metanephric tissue was present. The mature kidneys 
were entirely negative for LIM1. Samples from 10 to 35 
weeks of gestation demonstrated distinct nuclear stain-
ing of PAX2 in metanephric mesenchyme, comma- and 
S-shaped bodies, pretubular aggregates as well as imma-
ture glomeruli. The mature kidneys showed only focal 
faint nuclear positivity for PAX2 in the collecting ducts. 
Residual immature tubules in the sample of 35 weeks of 
gestation showed a distinct expression of PAX2 ( fig. 1 ). 
The sample from 7 weeks of gestation was not available 
for evaluation of PAX2 (also see table 3).
 Nephroblastomas 
 Thirty-two nephroblastomas were analyzed in our 
study, including 4 epithelial-type nephroblastomas, 2 
stroma-type nephroblastomas with ectopic mesenchy-
mal differentiation, 16 mixed nephroblastomas, 5 regres-
sive ones, 4 blastema-type ones and 1 cystic nephroblas-
toma.
 The cystic nephroblastoma showed mesenchymal and 
epithelial structures including immature glomeruloid 
bodies. All samples of regressive nephroblastomas con-
tained representative vital tumour areas with different 
structures. All 5 showed tubular structures, 4 of them 
mesenchymal areas and 2 additionally skeletal muscle,
Table 1.  Primer sequences
Gene Forward primer Reverse primer
Keratin 7 5CCCGGAATGAGATTTCAGAG 3 5GTAGGTGGCGATCTCGATGT 3
Lim1 5TCCAGGGAAGGCAAACTCTA 3 5TCATGCAGGTGAAGCAGTTC 3
18s RNA 5GTAACCCGTTGAACCCCATT 3 5CCATCCAATCGGTAGTAGCG 3
Table 2.  PCR conditions
Stage 1 50° C; 2 min
Stage 2 95° C; 10 min
Stage 3 95° C; 15 s
60° C; 1 min 
45 cycles
Dissociation stage 95° C; 15 s
60° C; 15 s
95° C; 15 s
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3 of them blastema and 1 also immature glomeruloid
bodies.
 Twenty of the nephroblastomas turned out to be en-
tirely negative on whole sections of the tumours. Eight of 
the negative tumours were mixed nephroblastomas, 2 re-
gressive ones, 2 stroma-type ones and 3 blastema-type 
nephroblastomas. All 4 epithelial-type nephroblastomas 
and also the cystic nephroblastoma revealed no expres-
sion of LIM1.
 One regressive nephroblastoma showed diffuse posi-
tivity of tubular epithelial structures, but no staining in 
the blastemal areas was present. Interestingly, all other 
nephroblastomas were only positive in focal areas of the 
tumour. Two regressive nephroblastomas harboured fo-
cal positivity in tubular epithelial structures, 1 blastema-
type nephroblastoma also showed positivity in tubular 
areas. Eight mixed nephroblastomas demonstrated dis-
tinct nuclear positivity for LIM1, 4 of them in areas of 
tubular epithelial structures, 1 in blastemal areas, 2 in 
blastemal and epithelial areas, 1 of them including tubu-
lar structures and immature glomeruloid bodies. One 
mixed nephroblastoma turned out to be focally positive 
in tubular structures and the mesenchyme surrounding 
these structures as well as immature glomeruloid bodies.
 In all nephroblastomas blastemal and epithelial struc-
tures were positive for PAX2. Additionally, 1 cystic 
nephroblastoma, 7 mixed nephroblastomas, 2 stroma-
type nephroblastomas and 1 regressive nephroblastoma 
showed positivity of the undifferentiated mesenchyme. 
In 6 mixed nephroblastomas and 1 stroma-type nephro-
blastoma the expression of PAX2 in the mesenchyme was 
focally concentrated around tubular structures. In con-
trast, in the cystic and the regressive nephroblastoma as 
well as in 1 stroma-type and 1 mixed nephroblastoma, 
diffuse positivity for PAX2 was noted in the mesenchyme 
(also see table 3). The sample of a regressive nephroblas-
toma with diffuse positivity for LIM1 harboured distinct 
nuclear staining in the epithelial region, but negativity of 
the mesenchyme ( fig. 2 , also see  table 3 ).
 Multicystic Dysplastic Kidneys 
 Eleven samples of multicystic dysplastic kidneys were 
included in the study. The dysplastic areas ranged from 
focal replacement of kidney parenchyma to entire multi-
cystic dysplastic kidneys. All samples were completely 
negative for LIM1 in the mesenchyme and in immature 
epithelial structures. All samples showed positivity for 
PAX2 in immature tubular structures, but no expression 
in the mesenchyme ( fig. 3 a–c).
 Renal Cell Carcinomas 
 Twenty-nine cases of renal cell carcinomas were inves-
tigated in our study, including 19 clear cell carcinomas 
and 10 papillary renal cell carcinomas. All of the samples 
a b
c d
 Fig. 1. Expression of LIM1 and PAX2 dur-
ing normal human kidney development. 
LIM1 is present in comma-shaped bodies 
( a ,  ! 400), S-shaped bodies ( b ,  ! 400) and 
pretubular aggregates ( c ,  ! 400), PAX2 in 
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containing large areas of tumours had no detectable pro-
tein expression of LIM1 ascertained by complete negativ-
ity with immunostaining against LIM1. In contrast, all 
carcinomas showed distinct nuclear positivity for PAX2 
( fig. 3 d–g, also see table 3).
 Additionally, QRT-PCR of 6 clear cell carcinomas and 
2 papillary cell carcinomas was performed. Like mature 
kidney, none of the samples showed detectable levels of 
mRNA expression.
 LIM1 Overexpression in a Cell Line 
 The MRC5 cell line not only features typical charac-
teristics of fibroblasts but has already been successfully 
used in transduction and immortalisation studies  [15] . 
Expression of  LIM1  was not detected in this cell line. 
Overexpression of  LIM1  in MRC5 cells induced a 3 times 
higher expression of  KERATIN7  compared to cells over-
expressing the control vector ( fig. 4 a). In contrast, a phe-
notypic alteration of the cells was not observed ( fig.
4 b, c).
 Cell cycle analysis was carried out in triplicates and 
showed one peak at G1 indicating diploidy. The percent-
age of cells within the phases of the cell cycle did not show 
a significant difference between cells overexpressing 
 LIM1  and the control vector ( fig. 4 d, e).
 Discussion 
 Regular nephrogenesis is the result of reciprocal inter-
actions between the ureteric bud, the condensed meta-
nephric mesenchyme surrounding the ureterical buds 
and the stromal mesenchyme. During this process the 







 Fig. 2. Staining pattern of LIM1 and PAX2 
in nephroblastomas. Distinct focal nuclear 
positivity of LIM1 can be seen in epithelial 
structures of a mixed nephroblastoma ( a , 
 ! 400), and a diffuse staining pattern in 
tubular structures of a regressive nephro-
blastoma ( b ,  ! 200). The epithelial-pre-
dominant nephroblastomas show no ex-
pression of LIM1 ( c ,  ! 200). PAX2 expres-
sion is identified in blastema ( d ,  ! 400), 
the epithelial component ( e ,  ! 400) and 
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epithelial elements giving rise to mature nephrons  [4, 
16] . Mouse models have demonstrated an essential role 
of  Lim1  during this process, as complete deficiency leads 
to renal agenesis  [9, 10] and conditional knock-out in re-
nal parenchyma to various renal malformations or dis-
eases  [11] . In our series of different stages of regular renal 
development we saw specific expression of LIM1 in 
structures derived from metanephric mesenchyme up to 
differentiation into immature glomerular structures be-
tween the gestational age of 10 and 30 weeks. No expres-
sion was detected in mature differentiated renal struc-
tures. These results parallel the role of  Lim1  described 
during kidney development in mice and rats  [5, 8] . PAX2 
is expressed in the condensing mesenchyme and struc-
tures of the renal vesicle, such as comma- and S-shaped 
bodies  [17] . In our series expression of PAX2 was in ac-
cordance with previously published data. Interestingly, 
in one sample of 35 weeks of gestation, minimal residual 
undifferentiated tubuli showed a distinct expression of 
PAX2. A deficiency in normal human renal development 
and a disorder of metanephric differentiation results in 
renal dysplasia, which is characterized by disorganized 
renal parenchyma. Primitive ducts that can also become 
cystic are lined by undifferentiated epithelium and sur-
rounded by undifferentiated mesenchyme. The morpho-
logical features described above can affect the whole kid-
ney or only a part of the organ and represent a develop-
mental abnormality with incomplete and abnormal 
differentiation  [18] . In a high percentage of cases, an ob-
struction of the renal system can be identified. The rea-
son for this obstruction, however, remains unexplained. 
It can be assumed, that the obstructive lesion and the 
malformed kidney result from changes in gene expres-




 Fig. 3. LIM1 is completely absent in em-
bryonal stroma and immature tubules of 
multicystic dysplastic kidney ( a ,  b ,  ! 400), 
renal clear cell carcinoma ( d ,  ! 400) and 
renal papillary carcinoma ( e ,  ! 400). Dis-
tinct expression of PAX2 can be seen in 
renal clear cell carcinomas ( f ,  ! 400), renal 
papillary cell carcinomas ( g ,  ! 400) and 
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been described in some cases with a heterogeneous pat-
tern of inheritance  [19, 20] . Genetic investigations of this 
entity have so far been sparse. Overexpression of  PAX2 
 and  SALL1  (sal-like 1) and ectopic expression of  BCL2  (B 
cell CLL lymphoma 2),  GALECTIN3  and hepatocyte nu-
clear factor 1  have been described  [20–22] . A micro-
array analysis of this lesion showed no upregulation of 
 LIM1  [23] , but in animal models deficiency of  Lim1  ex-
pression leads to a diminished size of the kidneys and 
hydronephrotic changes, mimicking the human coun-
terpart of this disease  [5] . In one patient with Mayer-
Rokitansky-Kuster-Hauser syndrome showing bilateral 
multicystic dysplastic kidneys a microdeletion at chro-
mosome 17q12 has been detected that includes among 
Table 3.  Summary of results
Sample Lim1 expression Pax2 expression
Developing kidneys
7 weeks of gestation negative not available
10–30 weeks of gestation positivity of apical tips of comma- and 
S-shaped bodies, pretubular aggregates, 
immature glomeruli
positivity of metanephric mesenchyme, comma- and 
S-shaped bodies, pretubular aggregates, immature 
glomeruli
35 weeks of gestation negative focal positivity of immature tubular structures







all negative 3 positivity of epithelial structures; 1 positivity of
epithelial structures, mesenchyme negative
2 stroma-type
nephroblastomas
all negative 2 positivity of tubular structures and mesenchyme
(1 diffuse and 1 focal)
16 mixed nephroblastomas 8 negative; 4 focal positive in tubular 
structures; 1 focal positive in blastema;
1 focal positive in blastema and tubular 
structures; 1 focal positive in blastema 
and tubular structures and glomeruloid 
bodies; 1 focal positive in tubular 
structures and surrounding mesenchyme 
and glomeruloid bodies
5 positivity of epithelial and blastemal structures,
focal positivity of mesenchyme; 7 positivity of 
epithelial and blastemal structures, mesenchyme 
negative; 1 positivity of epithelial structures, focal 
positivity of mesenchyme; 2 positivity of epithelial 
structures, mesenchyme negative; 1 positivity of 
epithelial structures, diffuse positivity of mesenchyme
5 regressive nephroblastomas 1 diffuse positivity of tubular structures; 
2 negative; 2 focal positivity of tubular 
structures
2 positivity of epithelial structures, mesenchyme 
negative; 2 positivity of epithelial and blastemal 
structures, mesenchyme negative; 1 positivity of 
epithelial structures, diffuse positivity of mesenchyme
4 blastema-type
nephroblastomas
3 negative; 1 positive in tubular 
structures
2 positivity of blastemal structures; 2 positivity of
blastemal and tubular structures, mesenchyme negative
1 cystic nephroblastoma negative positivity of epithelial structures, diffuse positivity of 
mesenchyme
Multicystic dysplastic kidneys




19 clear cell carcinomas negative positive
10 papillary renal cell
carcinomas
negative positive
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role of  LIM1  in the pathogenesis of nephroblastomas has 
not been investigated in detail to date. Microarray analy-
sis of a xenograft model of nephroblastomas  [28] and an 
additional microarray analysis of various subtypes of pri-
mary nephroblastomas indicated that overexpression of 
 LIM1  might play a role in their pathogenesis  [13, 28] . In 
our series of various subtypes of nephroblastomas only 1 
of 12 samples with LIM1 expression showed diffuse stain-
ing in tubular structures. In all remaining samples, re-
gardless of the morphological subtype, focal distinct nu-
clear positivity was detected, mostly in tubular structures 
but also in areas resembling immature metanephric mes-
enchyme and immature glomeruloid bodies. The expres-
sion of PAX2 in our samples paralleled previous findings 
 [3, 27] ; however, in some samples we were able to demon-
strate expression of PAX2 in the mesenchymal compo-
nent as well. In most samples PAX2 expression in mesen-
chyme was limited to focal areas, concentrating on mes-
enchymal layers around tubular structures. No obvious 
correlation could be identified between the expression 
patterns of LIM1 and PAX2.
several genes also  LIM1 . However, a direct association of 
 LIM1  deficiency and cystic kidneys could not be ascer-
tained  [24] . In our study we examined a series of multi-
cystic dysplastic renal lesions ranging from focal disar-
rangement of the parenchyma to involvement of the 
whole kidney. None of the lesions investigated showed 
any expression of LIM1 despite the upregulation of 
PAX2, an upstream activator of  LIM1  [25, 26] . Our study 
therefore reinforces the concept that  LIM1  deficiency 
might contribute to multicystic dysplastic kidneys.
 Nephroblastomas are intriguing embryonal neo-
plasms resembling different stages of renal development, 
both morphologically and genetically. Several transcrip-
tion factors that are active during renal development have 
also been found to be reactivated in nephroblastomas. 
These include HMGA2  (high mobility group AT-hook 2) 
 [13] ,  CITED1  [2] and  PAX2  [3] . Despite the already de-
scribed overexpression of  PAX2  in nephroblastomas in 
blastema and some epithelial structures by in situ hybrid-
ization  [3] and in the epithelial component by Western 
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 Fig. 4. Overexpression of  LIM1  induces a 
statistically significant increase in  KERA-
TIN7  expression ( * * *  p  ! 0.001) in a mes-
enchymal cell line ( a ) but no phenotypic 
change ( b ) compared to control ( c ). No dif-
ference was detected in cell cycle analysis 
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 Additionally, we evaluated more common renal neo-
plasms, clear cell carcinomas and papillary cell carcino-
mas of the kidney, for expression of  LIM1 .  LIM1  was nei-
ther detected on protein nor on mRNA levels. These re-
sults are in contrast to a recent study demonstrating 
positivity in 9 renal cell carcinomas by Western blot anal-
ysis  [29] . According to the information provided by the 
vendor of this antibody, however, it may exhibit cross-
reactivity with other proteins in Western blot analysis. 
Interestingly, in our study all samples of renal cell carci-
noma showed PAX2 expression, as already described for 
a majority in both tumour entities in different studies  [30, 
31] . These results and our findings indicate that PAX2 is 
activated in renal cell carcinomas, but does not induce 
expression of downstream genes of this signalling path-
way.
 During renal development  LIM1 plays a role in the in-
duction of an epithelial cellular phenotype  [5, 8] . In our 
cell culture model of a mesenchymal cell line, overex-
pression of  LIM1  led to an induction of expression of 
 KERATIN7 indicating a transformation towards an epi-
thelial phenotype, as KERATIN7 is typically expressed 
in simple epithelia, including the renal collecting ducts 
 [32] . Overexpression of  LIM1 , however, was not suffi-
cient to induce phenotypic changes in the cells. Cell cycle 
analysis of cell samples overexpressing  LIM1  showed no 
increased progression of the cell cycle.
 In conclusion, our study therefore strengthens the ev-
idence for a causative role of  LIM1  deficiency in the de-
velopment of multicystic dysplastic kidney and the im-
portance of  LIM1  in mesenchymal-epithelial transition. 
Expression of  LIM1  in most cases of nephroblastomas 
probably indicates a developmental phenomenon rather 
than an oncogenic activation, as has already been de-
scribed for other transcription factors such as  PTEN 
(phosphatase and tensin homolog on chromosome 10) 
 [33] . This is also corroborated by the lack of  LIM1  expres-
sion in various types of renal cell carcinomas. In a small 
subset of nephroblastomas with a more diffuse expres-
sion pattern, however,  LIM1  might contribute to the 
pathogenesis of these lesions.
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